Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View：Neutral
VRTXVertex Pharmaceuticals
FinDog View：Bullish
| Metric | GILD | VRTX |
|---|
| Close | 170.68 | 558.88 |
| Market Cap | $213B | $133B |
| 1M | +14.51% | +6.90% |
| P/E (TTM) | — | 30.6 |
| Forward P/E | 22.0 | 25.2 |
| P/E 5-Yr Percentile | — | 68 |
| P/S | 7.0 | 10.7 |
| P/B | 17.9 | 6.7 |
| Dividend Yield | 3.98% | — |
| Latest Quarter Revenue | $8.3B | $3.3B |
| Revenue YoY | +6.8% | +12.5% |
| Gross Margin | 81.1% | 85.3% |
| Latest Quarter EPS | 1.94 | 4.31 |
| Avg Post-Earnings Move | ±3.8% | ±6.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.57% | 1.51% |
| 90-Day Net Insider Buying | −$15.9M | — |
GILD · Revenue, Last 8 Quarters ($B)
VRTX · Revenue, Last 8 Quarters ($B)
